Wednesday, November 30, 2016 12:18:17 PM
All I know FOR SURE is that VirTra MUST deliver a pretty big Q4 when they report in March. The last 2 quarters of terrible revenue and no earnings has hurt my valuation argument and the stocks momentum.
If they deliver a $5mil Q4 with EPS of at least 6 cents then all will again be well. That would put them at 21.5 to 25 cents for 2016 depending on whether you ignore the 1X option charge in Q2.
If they lay an egg and come in again at 3mil with breakeven performance then the stock is at best dead for 6 months.
They also better handle the earnings release far more professionally than they just did in mid-Nov when the numbers got out during the market open time before the press release. That was bush league.
So for me, right now I am trusty the lumpiness argument with respect to Q to Q performance and believe they are positioning themselves for a decent 2016 close and stellar 2017.
Recent VTSI News
- VirTra Sets First Quarter 2024 Conference Call for Tuesday, May 14, 2024 at 4:30 p.m. ET • GlobeNewswire Inc. • 04/30/2024 12:00:00 PM
- VirTra to Introduce V-XR Training Solution at IAHSS Exhibition, Signaling Increased Commitment to Healthcare Security Training • GlobeNewswire Inc. • 04/29/2024 12:00:00 PM
- VirTra Awarded $5.9M Prototype Contract from U.S. Army IVAS Prime Contractor Microsoft • GlobeNewswire Inc. • 04/18/2024 12:00:00 PM
- VirTra Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/02/2024 10:00:00 AM
- VirTra Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/01/2024 08:05:00 PM
- VirTra Sets Fourth Quarter and Full Year 2023 Conference Call for Monday, April 1, 2024 at 4:30 p.m. ET • GlobeNewswire Inc. • 03/18/2024 12:00:00 PM
- VirTra to Participate in the 36th Annual ROTH Conference on March 17-19, 2024 • GlobeNewswire Inc. • 03/07/2024 01:00:00 PM
- VirTra CEO John Givens Appointed as Executive Committee Chair for National Center for Simulation • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- VirTra Debuts Advanced Training Content and True-Fire™ Recoil Kits at SHOT Show • GlobeNewswire Inc. • 01/18/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 09:05:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/21/2023 09:05:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2023 09:05:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 09:17:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 09:15:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2023 09:42:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2023 09:40:26 PM
- VirTra Debuts New Integration of VBS4 at I/ITSEC 2023 to Support Military Clients • GlobeNewswire Inc. • 11/29/2023 10:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/29/2023 09:19:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/29/2023 09:18:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 10:54:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 10:52:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 09:07:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 09:05:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/21/2023 03:54:26 PM
- VirTra Reports Third Quarter and Nine Month 2023 Financial Results • GlobeNewswire Inc. • 11/14/2023 09:05:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM